embryonic fibroblasts and their ability to promote NPR, apoptotic events, and changes in lamin A mobility was examined. Our results show that, in this system, Bax expression was sufficient to restore NPR such as in WT cells undergoing apoptosis. This activity of Bax was uncoupled from cytochrome c release from the mitochondria (indicative of MOMP) and required its membrane localization, α helices 5/6, and the Bcl-2 homology 3 (BH3) domain. Moreover, enrichment of Bax in the nuclear envelope by the so-called Klarsicht/ANC-1/Syne-1 homology domain effectively triggered NPR as in WT Bax, but without inducing MOMP or cell death. Bax-induced NPR was associated with impairment in lamin A mobility, implying a connection between these two nuclear envelope-associated events. Overall, the results indicate a new MOMP-independent, stress-induced Bax function on the nuclear envelope. 
Introduction
During apoptosis, proteins translocate from one cellular compartment to another to facilitate the apoptotic process. For example, in response to apoptotic stimuli, the pro-apoptotic Bcl-2 family protein Bax translocates from the cytosol to the mitochondria. There, it undergoes conformational changes which include exposure of its N-terminal region and the formation of homo-oligomers. This leads to mitochondrial outer membrane permeabilization (MOMP), causing additional apoptotic translocation events, with apoptogenic mitochondrial proteins such as cytochrome c, Smac/DIA-BLO, and HtrA2/Omi being released into the cytosol [1] [2] [3] . In the cytosol, cytochrome c promotes apoptosome formation, caspase-9 activation, and the cleavage and activation of the effector caspases 3 and 7 [4] . Several domains are crucial for Bax-mediated MOMP and cell death. These include the Bcl-2 homology domain BH3, which participates in homo-oligomerization and the interaction of Bax with the hydrophobic pocket of anti-apoptotic Bcl-2 family proteins, as well as α-helices 5 and 6. The latter are structurally homologous to bacterial toxins and required for the insertion of Bax into the outer mitochondrial membrane and its consequent pore-forming activity.
In addition to the translocation of proteins from the mitochondria to the cytosol, nuclear proteins such as p53, Nur77, Histone H1.2, nucleophosmin (NPM), and nucleolin have been shown to translocate from the nucleus to the cytosol or mitochondria during apoptosis, where they participate in the apoptotic process (for review, see [5] ). We recently discovered that stress-induced nuclear protein redistribution (NPR) is regulated by Bax and Bak (Bax/Bak). This Bax/Bakmediated effect is independent of N-terminal conformational changes of Bax or Bak, the apoptosome and caspase activity, and is unaffected by Bcl-x L over-expression [6] . Re-expression of Bax or Bak in Bax/Bak double-knockout (DKO) mouse embryonic fibroblasts (MEFs) restored the stress-induced NPR by a mechanism which resembled that in stressed wild-type (WT) MEFs, since it was not inhibited by the general caspase inhibitor BOC-Asp(OMe)-FMK [6] . The present study explores the molecular details of NPR induced by WT and various mutants of Bax re-expressed in Bax/Bak DKO MEFs as the model system. We show that the same domains of Bax are crucial for NPR and for MOMP and cell death. However, targeting Bax to the nuclear envelope (NE) using the Klarsicht/ANC-1/Syne-1 homology (KASH) domain was sufficient for NPR in the absence of MOMP and cell death. Thus, our results point to a novel non-canonical, MOMP-independent action of Bax at the NE which leads to NPR.
Materials and methods

Materials
All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise specified. Quinolineval-asp(OMe)-CH2-OPH (Q-VD-OPH) was purchased from R&D Systems (Minneapolis, MN, USA).
Cell culture
Primary WT and Bax/Bak DKO MEFs were obtained from Andreas Strasser (The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia). They were immortalized by the 3T9 method [7] and grown in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % heat-inactivated fetal calf serum.
Plasmids
The expression vectors used in this study were: pEGFP (Clontech Laboratories, Mountain View, CA, USA), pEGFPBax (GFP-Bax), ΔN(1-20) Bax and FLAG-Bax prepared as described [8] ; pcDNA3 HA-Bax (HA-Bax) prepared as described [9] ; FLAG-Bcl-x L prepared as described [10] ; GFP-Bax L63E [Leu 63 (CTC) was replaced by Glu (GAG) using the forward primer: 5′ GAAGCTGAGCGAGTGT GAGAAGCGCATCGGGG and the reverse primer: 5′ CCCCGATGCTCTTCTCACACTCGCTCAGCTTC], GFP-Bax ΔIGDE (deletion of residues 66-69 using the forward primer: 5′ GTCTCAAGCGCCTGGACAGTAA CATGGAGC and the reverse primer: 5′ GTTACTGTCCA GGCGCTTGAGACACTCGCTC) and GFP-Bax Δα5/6 (deletion of residues 108-146 using the forward primer: 5′ CCGAGTGGCAGCTGACATGTGGATCCAAGACCAGG GTGGTTGG and the reverse primer: 5′ CCAACCACC CTGGTCTTGGATCCACATGTCAGCTGCCACTCGG) were prepared by two-step PCR amplification, using the above-mentioned primers for the first PCR step and GFPBax as a template. For the second step, the first step PCR products were used as templates employing the forward (5′ GTCACTCGAGATGGACGGGTCCGGGGAGCAGC) and reverse (5′ GTCAGAATTCTTAGCCCATCTTCTTC CAGATGG) primers containing XhoI and EcoRI sites. The final PCR products were cloned into XhoI-EcoRI sites of pEGFP. GFP-Bax 63-65A and GFP-Bax 92-94A were a gift from Xu Luo (University of Nebraska Medical Center, Omaha, NE, USA); GFP-Mito-Bax was prepared by in-frame insertion of the NheI/AgeI mitochondrial targeting fragment from pEYFP-Mito (Clontech Laboratories, Mountain View, CA, USA) into NheI/AgeI sites in GFP-Bax; GFP-Bax S184V was a gift from Richard Youle (National Institutes of Health, Bethesda, MD, USA); Bax Cyt b5 was generated by subcloning a PCR fragment corresponding to the C terminus of rat microsomal cytochrome b5 (Cyt b5) (aa 100-134, cDNA kindly provided by Stephen Sligar, Urbana, IL, USA) into the PmlI (in Bax) and XbaI (in the multiple cloning site of pcDNA3) sites of hBax/pcDNA3, thereby replacing the C terminus of Bax with that of Cyt b5; HA-Bax NLS was prepared by inserting an NcoI/XhoI fragment containing HA-Bax (generated by PCR using pcDNA3 HA-Bax as a template and the forward: 5′ GTCACCATGGTCCACCATGGCATACCCATACG and reverse: 5′ CGATCTCGAGGCCCATCTTCTTCCAGAT GG primers) into the NcoI/XhoI sites of pCMV/myc/nuc (Invitrogen Life Technologies, Paisley, UK). FLAG-Bax KASH was prepared by two-step PCR that joined Bax and KASH sequences in frame. In the first step, the forward: 5′ GTCAGATATCTGACGGGTCCGGGGAGCAGCCCAG AGG and reverse: 5′ GGAGGAGCAGCTGCAGGGGTAG GGCGCCCATCTTCTTCCAGATGGTGAGCG primers and pEGFP-Bax as template or the forward: 5′ CGCT-CACCATCTGGAAGAAGATGGGCGCCCTACCC CTGCAGCTGCTCCTCC and reverse: 5′ GTCATCTAGA CTATGTGGGGGGTGGCCCATTGG primers and pTREmBcl-2-KASH [12] as a template were used. For the second PCR step, the products of the first step were used as templates using the forward: 5′ GTCAGATATCTG ACGGGTCCGGGGAGCAGCCCAGAGG and the reverse: 5′ GTCATCTAGACTATGTGGGGGGTGGCCCATTGG primers and the Bax KASH PCR product was cloned into the EcoRV/XbaI sites of FLAG-pcDNA3 [11] ;GFP-Bax ΔTM and GFP-Bax P168A were prepared as described [8] ; pDsRed-Mito was from Clontech Laboratories, Cherry-LAP2β was a gift from Eran Bacharach (Tel Aviv University, Tel Aviv, Israel), and pHcRed1-Nuc was a gift from Adi Kimchi (Weizmann Institute of Science, Rehovot, Israel); FLAG-Δα5/6 Bax KASH was prepared by twostep PCR amplification. In the first step, the forward: 5′ GTCAGATATCTGACGGGTCCGGGGAGCAGCCCAG AGG and reverse: 5′ CCAACCACCCTGGTCTTGGAT CCACATGTCAGCTGCCACTCGG or the forward: 5′ CCGAGTGGCAGCTGACATGTGGATCCAAGACC AGGGTGGTTGG and the reverse: 5′ GTCATCTAGACT ATGTGGGGGGTGGCCCATTGG primers and FLAGBax KASH as a template were used. In the second step, the products of the first PCR step were used as templates using the forward: 5′ GTCAGATATCTGACGGGTCC GGGGAGCAGCCCAGAGG and reverse: 5′ GTCATCTAG ACTATGTGGGGGGTGGCCCATTGG primers. The PCR product of the second step was inserted into the EcoRV/XbaI sites of pcDNA3-FLAG. FLAG-L63E Bax KASH was prepared by two-step PCR amplification. In the first step, the forward: 5′ GTCAGATATCTGACGGGTCCGG GGAGCAGCCCAGAGG and reverse: 5′ CCCCGATG CTCTTCTCACACTCGCTCAGCTTC or the forward: 5′ GAAGCTGAGCGAGTGTGAGAAGCGCATCGGGG and the reverse: 5′ GTCATCTAGACTATGTGGGGGGTGGC-CCATTGG primers and FLAG-Bax KASH as a template were used. In the second step, the products of the first PCR step were used as templates using the forward: 5′ GTCAG ATATCTGACGGGTCCGGGGAGCAGCCCAGAGG and reverse: 5′ GTCATCTAGACTATGTGGGGGGTGGCCC ATTGG primers. The PCR product of the second step was inserted into the EcoRV/XbaI sites of pcDNA3-FLAG.
Bcl-x L KASH (with a FLAG tag at its N terminus) was prepared by two-step PCR that joined Bcl-x L and KASH in frame. In the first step, the forward: 5′ GCTGGAATTCAC-CATGGATTACAAGGACG and reverse: 5′ GGAGG AGCAGCTGCAGGGGTAGGGCTTTCCGACTGAAG AGTGAGCCC primers and FLAG-Bcl-x L as a template or the forward: 5′ GGGCTCACTCTTCAGTCGGAAAG CCCTACCCCTGCAGCTGCTCCTCC and reverse: 5′ GT CATCTAGACTATGTGGGGGGTGGCCCATTGG primers and pTRE-mBcl-2-KASH as template were used. In the second step, the PCR products of the first step were used as templates using the forward: 5′ GCTGGAATTCACC and the reverse: 5′ GTCATCTAGACTATGTGGGGGGTGGC CCATTGG primers. The Bcl-x L -KASH PCR product was inserted into the EcoRI/XbaI sites of pcDNA3; Bcl-x L Cyt b5 was generated by subcloning a PCR fragment of rat Cyt b5 (see Bax Cyt b5 above) into the SphI (in Bcl-x L ) and XbaI (in the multiple cloning site of pcDNA3) sites of hBclx L /pcDNA3, thereby replacing the C terminus of Bcl-x L with that of Cyt b5; Lamin A-RFP [13] GFP-mini-nesprin-2G [14] were a gift from Howard J. Worman (Columbia University, NY, USA); GFP-tBid was a gift from Atan Gross (Weizmann Institute of Science, Rehovot, Israel) and GFPBcl-x S was prepared as described [9] . Immunofluorescence staining Cells were grown in 12-well plates, 10 5 cells per dish, on 18-mm cover slips coated with collagen; 24 h after transfection, cells were fixed and stained with the different antibodies and Hoechst dye 33258, as described previously [15] . The following primary antibodies were used: rabbit anti-nucleolin C23 (H-250) and rabbit anti-calnexin (both from Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-FLAG M5 and rabbit anti-HA (both from Sigma-Aldrich), mouse anti-HA (12CA5, purified from hybridomas), mouse anti-NPM (Zymed Laboratories, San Francisco, CA, USA) mouse anti-histidine TAG (AbD; Serotec, NC, USA), rabbit anti-Bax-N terminal (NT) (Millipore, MA, USA), mouse anti-Bax NT (6A7 antibody) and mouse anti-cytochrome c (both from BD Pharmingen™, MD, USA) and rabbit anti-GAPDH (Cell Signaling Technology, MA, USA). Fluorescent images were captured with a fluorescence microscope (Nikon ECLIPSE TE2000-S) connected to a CCD camera (CoolSNAP HQ; RoPER Scientist) with plan Apo VC 60×/1.4 oil-immersion objective using Image-Pro PLUS (v.4.5.1) software (Media Cybernetics) and exported to Photoshop (Adobe). To determine the number of cells exhibiting the redistribution effect or apoptotic nuclei (exhibiting nuclear condensation or fragmentation), the fluorescently stained cells were counted under the fluorescence microscope. Confocal fluorescent images were obtained using a Meta Zeiss LSM 510 confocal microscope using Zeiss X63 NA 1.4 objective lens. Images were acquired with Zeiss LSM Image Browser v.4.2.0.121.
FRAP analysis
Cells were plated on a 35-mm 2 glass-bottom dish (Greiner Bio-One, Frickenhausen, Germany), transfected with lamin A-RFP with or without additional plasmids and imaged 24 h later. Imaging medium was similar to growth medium, but consisted of DMEM without phenol red. The imaging setup consisted of an iMIC inverted microscope with an oilimmersion Plan-Apochromatic 60× objective NA = 1.42 (Olympus), a Polychrome V system (TILL Photonics, Gräfelfing, Germany), 561 nm 75 mW DPSS laser "Jive" (Cobolt), a polytrope condenser (iMIC Beam-switch for widefield, TIRF, FRAP illumination) and an ANDOR iXon DU 888D EMCCD camera (Andor, Belfast, UK). The microscope was in a 37 °C temperature-controlled chamber with 5 % CO 2 atmosphere. The equipment was controlled by Live Acquisition Software (TILL Photonics). Two baseline images were taken prior to the bleaching. The bleach pulse was for 600 ms at 80 % laser intensity. Bleaching area was two lines drawn across the nucleus from the nuclear rim through the nucleoplasm. Recovery of fluorescence was monitored at 30-s intervals for 30 min. The average intensity of the fluorescent signal was measured in two regions of interest: rim [a bleached area at the nuclear periphery corresponding to the regions which exhibit higher fluorescent intensity than the nuclear interior (marked by arrow and rectangle, Fig. 7a , right panel)] and nucleoplasm [bleached area in interior of the nucleus (marked by arrowhead, Fig. 7a , right panel)]-using Metamorph software (Molecular Devices, CA, USA). It was then normalized to the change in total fluorescence as I rel = T 0 I t /T t I 0 where T 0 is total cellular intensity during pre-bleach, T t is total cellular intensity at time t, I 0 is the average intensity in a region of the pre-bleached nucleus corresponding to the bleach region, and I t is the average intensity in the bleach region at time t [16] . The normalized fluorescence was then plotted against time after bleaching. Mobile fraction (% recovery) was calculated as I rel t =30 − I rel t =bl × 100/ 1 − I rel t =bl , where I relt =30 is the intensity after 30 min and I rel t =bl is the intensity after the bleach .
Results
Re-expression of Bax in Bax/Bak DKO MEFs restores stress-induced NPR by a mechanism which resembles stress-induced NPR in WT MEFs
In a previous study, we showed that Bax/Bak regulate stressinduced NPR in WT MEFs and that this effect is caspaseindependent and not inhibited by Bcl-x L over-expression [6] . To recapitulate stress-induced NPR, we transiently re-expressed a green fluorescent protein (GFP)-tagged version of Bax in Bax/Bak DKO MEFs [6] and tested whether Bcl-x L is still unable to block this process. Since caspase inhibition does not affect stress-induced NPR [6] , this and subsequent experiments were performed in the presence of the broad-spectrum caspase inhibitor, Q-VD-OPH, to attenuate Bax-induced cell death. Note that, in these cells, GFP-Bax transfection alone triggered apoptosis without any additional apoptotic stimuli. As shown in Fig. 1a , GFPBax expression caused redistribution of nucleolin 24 h after transfection, as indicated by its appearance in the cytoplasm and reduced expression in the nuclei and nucleoli. However, this redistribution was not affected by co-expression with Bcl-x L , although Bcl-x L effectively inhibited GFP-Baxinduced cytochrome c release, that is, cytochrome c was retained in punctuated mitochondrial structures (Fig. 1a) . Similar results were obtained for NPM and histone H1 redistribution (Supplemental Fig. S1 ) or when hemagglutinin (HA)-Bax was used instead of GFP-Bax ( Values are presented as mean ± SD (error bars), (n = 3). One-way ANOVA revealed a significant effect of treatments (p < 0.001) for both nucleolin and cytochrome c redistribution. Tukey's post hoc analysis revealed that the level of both nucleolin and cytochrome c redistribution were significantly higher in the HA-Bax and HA-Bax plus Bcl-x L treatments compared to the control pEGFP treatment (*p < 0.05). However, whereas the effect of the HA-Bax plus Bcl-x L treatment on cytochrome c release was significantly lower than that of the HA-Bax treatment ( # p < 0.05), the effects of these treatments on nucleolin redistribution were similar redistribution of nucleolin, but blocked cytochrome c release (Fig. 1b) . Moreover, we previously reported that NPR induced by Bax re-expression in Bax/Bak DKO MEFs is also independent of caspases [6] . We therefore found this system suitable for identifying the molecular mechanism governing Bax-induced NPR.
We then examined whether other pro-apoptotic Bcl-2 family members might induce NPR following their expression in Bax/Bak DKO MEFs. The pro-apoptotic proteins tBid (which represents BH3-only proteins) and Bcl-x S (which acts as a BH3-only protein but also contains a BH4 domain [17] ) were expressed in Bax/Bak DKO MEFs. As shown in Fig. 2 , neither GFP-tBid nor GFP-Bcl-x S expression induced NPR in these cells. This suggested that the NPR effect is specifically induced by Bax or Bak, and not by other pro-apoptotic Bcl-2 family proteins.
Bax-induced NPR and MOMP/apoptosis require the same functional domains of Bax Bax contains nine amphipathic α-helices (1-9) [18] and three BH domains (BH1, BH2, and BH3) [19] . The BH3 domain (containing α-helix 2) and α-helices 4 and 5 are required for both the oligomerization and killing activity of Bax [20] [21] [22] . α-Helices 5 and 6 of Bax form a hairpin structure proposed to act as a pore-forming domain, and are necessary for its toxic effect [23] . The N′ terminus of Bax, which contains α-helix 1, is important for its conformational Presented results are expressed as the percentage of cells exhibiting both nucleolin redistribution and pEGFP, GFP-Bax, GFP-tBid or GFP-Bcl-x S expression, from the total population of pEGFP-, GFPBax-, GFP-tBid-or GFP-Bcl-x S -expressing cells (at least 100 cells). Values are presented as mean ± SD (error bars) (n = 3). A one-way ANOVA revealed a significant effect of treatments (p < 0.001). Tukey's post hoc analysis revealed that the effect of the GFP-Bax treatment on nucleolin redistribution was significantly higher than that of the pEGFP control treatment and the GFP-tBid and the GFP-Bcl-x S treatments (*p < 0.05). Furthermore, no significant difference was observed between the pEGFP control treatment and the GFP-tBid and the GFP-Bcl-x S treatments change, mitochondrial targeting and full activation following mitochondrial translocation [24] . To identify which domains are needed for Bax-induced NPR, we generated His-tagged and GFP-tagged Bax mutants in which these various functional domains/helices were mutated or deleted (Fig. 3a) . As with the WT Bax above, these mutants were expressed in Bax/Bak DKO MEFs (Supplemental Fig. S2 ) and tested for their capacity to trigger NPR, cytochrome c release, and cell death. Expression of WT GFP-Bax induced nucleolin redistribution, which was about threefold higher than that induced by the control vector pEGFP (Fig. 3b) . the cells for apoptotic nuclei yielded the same result as for NPR induction: whereas ΔN(1-20) Bax induced condensed nuclei to a similar extent as WT GFP-Bax, the BH3, oligomerization, and pore-forming mutants of GFP-Bax all failed to induce apoptotic nuclei (Fig. 3c) . Examination of cytochrome c release in the Bax/Bak DKO MEFs transfected with the different Bax mutants revealed variable degrees of release (Fig. 3d) . The toxic WT GFP-Bax caused complete cytochrome c release, as reflected by diffuse staining without any confined punctuated regions. In contrast, the nonapoptotic GFP-Bax mutant Δα5/6 did not reveal any diffuse cytochrome c staining at all. However, partial cytochrome c release with interspersed punctuated mitochondrial staining was noted for the BH3 and oligomerization mutants of GFP-Bax ( Fig. 3d; Supplemental Fig. S3 ), although these variants were not cytotoxic (Fig. 3c) . The ability of these Bax mutants to partially promote cytochrome c release without triggering NPR indicated that MOMP (cytochrome c release) is insufficient to mediate NPR. Taken together, our results suggested that Bax-induced NPR requires the same domains as Bax-induced cell death and that NPR and cytochrome c release are uncoupled.
Targeting of Bax to the NE triggers NPR, but not MOMP/ apoptosis
We hypothesized that the non-canonical action of Bax on NPR might be exerted at a particular intracellular site such as the NE. To test this, we targeted Bax to specific subcellular localizations using the following constructs ( Fig. 4a) : GFP-Mito-Bax, (targets Bax to the mitochondria using the cytochrome c oxidase targeting sequence [25] ), GFP-Bax S184V (targets Bax to the mitochondria due to the S184V mutation which results in constitutive mitochondrial localization of Bax [26] ), Bax Cyt b5 (targets Bax to the ER using the cytochrome b5 targeting sequence [27] ), HA-Bax NLS (targets Bax to the nucleoplasm due to the addition of nuclear localization sequences [28] ), FLAG-Bax KASH (targets Bax to the NE via the KASH domain, a sequence responsible for targeting nesprin-2 to the outer NE [29] ), GFP-ΔTM Bax (targets Bax to the cytosol due to deletion of the Bax transmembrane domain), and GFP-Bax P168A (targets Bax to the cytosol due to the P168A mutation, which prevents translocation of Bax to mitochondria [8] ). Following transfection into Bax/Bak DKO MEFs, we tested the correct subcellular localization of the different Bax constructs by co-immunostaining with organelle-specific antibodies or expression of fluorescent organellespecific marker proteins. As expected, GFP-Bax ΔTM was observed throughout the cell like glyceraldehyde 3-phosphate dehydrogenase (GAPDH), GFP-Bax P168A exhibited a diffuse cytoplasmic distribution, Bax Cyt b5 exhibited similar tubular distribution as the ER marker calnexin, GFP-Mito Bax and GFP-Bax S184V exhibited similar punctuated distribution as the mitochondrial marker pDsRed-Mito, HA-Bax NLS exhibited similar nucleoplasm distribution as the nuclear marker HcRed1-Nuc, and FLAG-Bax KASH exhibited similar NE distribution as the NE protein Cherry-LAP2β (Supplemental Fig. S4 ), although it was also observed in other regions, e.g., the ER. We then tested the ability of the variously targeted Bax constructs to induce NPR, cytochrome c release, and cell death. As shown in Fig. 4b , targeting Bax to the mitochondria, the ER, or the NE effectively promoted nucleolin redistribution. This was not the case with the cytoplasmic and nucleoplasmic constructs, which also did not induce cytochrome c release or apoptosis, whereas mitochondria-and ER-targeted Bax provoked these two responses, as expected (Fig. 4c, d ). The most interesting Bax variant was FLAG-Bax KASH. This variant, which was associated with the NE, did not provoke either cytochrome c release or apoptosis (Figs. 4c,  d, 5 ), but induced nucleolin redistribution which was as effective as that induced by WT Bax (Figs. 4b, 5 ). This latter observation reinforced the notion that Bax-induced NPR differs from its canonical, pro-apoptotic function in the mitochondria, ER or both, and that this novel function of Bax might be performed at the NE, the site where NPR occurs. or anti-FLAG (for FLAG-Bax KASH) antibodies and with Hoechst dye. Thereafter, the number of cells exhibiting nucleolin redistribution, cytochrome c release or apoptotic nuclei was determined microscopically as described in Fig. 3 . Values are presented as mean ± SD (error bars) (n = 3). A one-way ANOVA revealed a significant effect of treatments for each nucleolin redistribution, apoptotic nuclei and cytochrome c release (p < 0.001). Tukey's post hoc analysis revealed that the effects of GFP-Bax and the Bax variants GFP-Mito-Bax, GFP-Bax S184V, Bax Cty b5 and FLAG-Bax KASH on nucleolin redistribution (b) were significantly higher than the similar effects of the control pEGFP treatment and the Bax variants HA-Bax NLS, GFP-Bax ΔTM and GFP-Bax P168A (*p < 0.05); the effects of GFP-Bax and the Bax variants GFP-Mito-Bax, GFP-Bax S184V and Bax Cty b5 on apoptotic nuclei (c) or cytochrome c release (d) were significantly higher than the similar effects of the control pEGFP treatment and the Bax variants HA-Bax NLS, FLAG-Bax KASH, GFP-Bax ΔTM and GFP-Bax P168A (*p < 0.05) ▸ FLAG-Bax KASH-induced NPR is also caspaseindependent and not inhibited by Bcl-x L Because Bax KASH uncouples MOMP and cell death from NPR, this Bax version serves as an ideal model for studying Bax-induced NPR without interfering with its pro-apoptotic function. Therefore, we further characterized the NPR effect induced by expressing FLAG-Bax KASH in Bax/Bak DKO MEFs and compared it to that of a control KASH containing the GFP-mini-nesprin-2G construct. As shown in Fig. 6a , FLAG-Bax KASH induced redistribution of all three nuclear proteins-nucleolin, NPM, and histone H1-which was 2-3 fold higher than that caused by GFP-mini-nesprin-2G, indicating that the NPR effect is due to Bax and not the KASH domain alone (Fig. 6b) . The FLAG-Bax KASH-induced redistribution of the different nuclear proteins exhibited similar patterns as previously described for stress-induced NPR [6] . Accordingly, NPM was evenly distributed in the cytoplasm. Nucleolin exhibited a granular cytoplasmic staining pattern and reduced expression in nuclei, and the nuclear staining of H1 was markedly reduced. The ability of FLAG-Bax KASH to promote redistribution of a previously expressed NLS-containing reporter was also examined. Bax/Bak DKO MEFs were transfected with the pHcRed1-Nuc vector, which directs nuclear targeting of the NLS-containing reporter HcRed1. After 24 h, these cells were re-transfected with either FLAG-Bax KASH or GFP-mini-nesprin-2G. After an additional 24 h, the percentage of reporter-expressing cells that exhibited cytosolic HcRed1 was determined microscopically. As exemplified by the representative cells depicted in supplemental Fig. S5 and confirmed by quantitative analysis, similar to its effect on endogenous nuclear proteins, FLAG-Bax KASH was substantially and significantly more effective in promoting redistribution of the nuclear reporter compared to GFP-mini-nesprin-2G (78 ± 5.2 vs. 18.6 ± 2.3 %, respectively; p = 0.000658 two-tailed t test, n = 3). Importantly, as seen for WT Bax, co-expression of Bcl-x L with FLAGBax KASH or treatment of FLAG-Bax KASH transfectants with the caspase inhibitor Q-VD-OPH did not impede the ability of this construct to induce NPR (Fig. 6c) , confirming that this process is non-canonical, that is, independent of caspases and not inhibited by Bcl-x L . Moreover, mutation of the BH3 domain (L63E) or deletion of α-helices 5/6 in FLAG-Bax KASH substantially inhibited the NPR effect (Fig. 6d ), but not targeting to the NE (although it did increase its ER-like localization) (Supplemental Fig. S6 ). These results indicated that FLAG-Bax KASH-induced NPR recapitulates the NPR induced by WT Bax. The inability of Bcl-x L to inhibit FLAG-Bax KASHinduced NPR might have been due to a different subcellular localization of the two proteins. To test this, we generated Bcl-x L KASH and Bcl-x L Cyt b5 to target Bcl-x L to the NE or ER, respectively. However, as with WT Bcl-x L , neither of the targeted Bcl-x L constructs was capable of impairing nucleolin redistribution triggered by FLAG-Bax KASH (Fig. 6e) . These results demonstrated that the inability of Bcl-x L to inhibit the FLAG-Bax KASH-induced NPR effect is not due to different subcellular localization of the two proteins.
Expression of Bax or Bax KASH impairs lamin A mobility
It is reasonable to assume that Bax regulates NPR by changing NE permeability. Therefore, it is interesting to examine if such changes are associated with alterations of the lamina, since an intact lamina is one prerequisite for a functional NE permeability barrier. To gain some insight into such functionality, we studied the effect of Bax on mobility of lamin A, a major constituent of lamina [30] , to detect potential alterations. Lamin A mobility was analyzed using fluorescence recovery after photobleaching (FRAP), an assay which assesses the dynamics of fluorescent proteins in living cells. Bax/Bak DKO MEFs were transfected with lamin A-RFP alone or together with FLAG-Bax, in the presence or absence of the general caspase inhibitor Q-VD-OPH or with Bcl-x L or FLAG-Bax KASH. After 24 h, a region at the nuclear lamina was bleached and the recovery of fluorescent lamin A-RFP was monitored at both the nuclear rim and the nucleoplasm over a period of up to 30 min (Fig. 7a, b) . As previously shown in other cell types (for review see [30] and references therein), in Bax/Bak DKO MEFs transfected with lamin A-RFP alone, the influx of fluorescent lamin A protein into the bleached area was inefficient at both the nuclear rim and in the nucleoplasm (Fig. 7a, b) . Quantitative analysis (Fig. 7c) revealed a low-mobile fraction (19.7 ± 3 and 17.9 ± 2.8 % at these two sites, respectively) of lamin Values are presented as mean ± SD (error bars) (n = 3). A one-way ANOVA revealed a significant effect of treatment (p < 0.001). Tukey's post hoc analysis revealed that the effect of FLAG-Bax KASH on nucleolin redistribution was significantly higher than in the two FLAG-Bax KASH mutants (*p < 0.05). e Quantification of the percentage of cells exhibiting nucleolin redistribution in FLAG-Bax KASH-expressing cells without (Con) or with Bcl-x L , Bcl-x L KASH or Bcl-x L Cyt b5. Bax-expressing cells were identified by staining with anti-Bax NT antibodies. The percentage of the different FLAG-Bax KASH-expressing cells exhibiting nucleolin redistribution was determined as described in Fig. 3 . Values are presented as mean ± SD (error bars) (n = 3). A one-way ANOVA did not reveal a significant effect of treatment A-RFP, 30 min after photobleaching (n = 23 cells). In contrast, co-expression with Bax or Bax KASH increase lamin A-RFP mobility ( Fig. 7a and b) resulting in a significant increase in its mobile fraction (48.6 ± 4.7 and 56.3 ± 5.7 % for Bax; 52.4 ± 6.4 and 50.1 ± 8.4 % for Bax KASH, at the nuclear rim and nucleoplasm, respectively) (n = 25 and 11 cells respectively). Notably, a significant increase in the mobile fraction of lamin A-RFP was also induced when the cells were co-transfected with FLAG-Bax and Bcl-x L (47.9 ± 3.7 and 49.3 ± 4 % at the nuclear rim and b a c nucleoplasm, respectively) (n = 24) or treated with Q-VD-OPH (77.2 ± 10.2 and 73 ± 7.9 %, respectively) (n = 23) (Fig. 7c) . In fact, the latter was even higher than with Bax alone. Taken together, our results indicated that both Bax and Bax KASH impair the integrity of the lamin A network via a mechanism that is unaffected by Bcl-x L over-expression or caspase inhibition, suggesting that Bax affects NPR via its effect on lamin A network.
Discussion
Bax and Bak are essential mediators of apoptotic stimuli. Their pro-apoptotic action encompasses many aspects, such as direct or indirect perforation of the mitochondrial outer membrane [21] , regulation of mitochondrial fission [31] , and promotion of Ca 2+ leakage through the ER membrane [32] . All these processes are associated with a conformational change at the N' termini of Bax and Bak, and they are effectively inhibited by Bcl-2-like pro-survival proteins. Recently, we showed that Bax and Bak can also regulate stress-induced NPR. This function seems to be mediated via a non-canonical, novel mechanism that is uncoupled from Bcl-x L inhibition and N-terminal exposure [6] . Here, we substantiated these results and explored the molecular details of this new process by directly studying the effect of over-expressed Bax on NPR in Bax/Bak DKO MEFs. Our results show that Bax requires the same functional domains for its NPR effect as for promoting cell death (BH3, oligomerization, and pore-forming domains). However, as previously shown, Bax-induced NPR is not blocked by Bcl-x L over-expression or caspase inhibition. Strikingly, the Bax KASH variant which exhibited enriched expression in the NE provoked NPR in a similar fashion as WT Bax or Bax targeted to mitochondria or the ER, but it no longer induced apoptosis. With this form of Bax, we can therefore study the impact of Bax on NPR independently of its effect on apoptosis. We also found that Bax-induced NPR is associated with impairment in the integrity of the laminar meshwork and this effect was not inhibited by Bcl-x L over-expression or caspase inhibition. Thus, our findings here lend support to a novel function of Bax on the NE that occurs in parallel to apoptosis induction but is uncoupled from its canonical action on MOMP.
What might be the mechanism by which Bax promotes NPR? The targeting experiments suggest that at least part of the effect is mediated by a Bax localized to the NE. Although the current view is that mitochondria and the ER are the major sites of action of Bax/Bak, a nuclear function for these proteins has also been proposed. Bax has been reported to be localized in nuclei of healthy mammalian cells [33] [34] [35] . Moreover, during apoptosis, in addition to translocation to the mitochondria and ER, Bax can also translocate to the NE [36] [37] [38] . Thus, we postulate that, in response to apoptotic stimuli, Bax not only causes permeabilization of the outer mitochondrial (MOMP) and ER membranes [39] but a certain NE-associated proportion of it may also be capable of perforating the NE. The mechanism underlying this NE permeabilization is currently unknown. However, it is unlikely to involve the nuclear export system or the degradation of nuclear pore components, because the nuclear export inhibitor leptomycin B, calpain inhibitor (data not shown), and caspase inhibitors did not impede stress-induced NPR, and stress-or Bax-induced NPR was not affected by the treatment with pan-caspase inhibitors. Rather, we propose that Bax somehow destabilizes the nuclear membrane and therefore leads to a rearrangement of the nuclear lamina and its associated proteins. Interestingly, some lamin A mutations which cause laminopathy have been shown to increase lamin A mobility [40] . Alternatively, Bax may interact with one or more nucleoskeleton proteins and linker of nucleoskeleton-and cytoskeleton-complex proteins, such as nesprins and SUN proteins, thereby perturbing the nuclear lamina. Another possibility is that Bax proteins form pores in the nuclear membrane in a manner similar to their action on the mitochondrial outer membrane. This latter possibility is supported by our finding that Bax-induced NPR depends on the pore-forming α-helices 5 and 6 and the oligomerization domain (required for pore formation). Targeting Bax to the mitochondria also promotes NPR, but the mechanism governing this process may differ from that of nuclear Bax. Further studies are needed to unravel the exact molecular mechanism by which Bax perforates the NE. The role of NPR in apoptosis is unclear. Although it has been shown in some cases to participate in the apoptotic process [5] , its outcome most likely depends on cell type and the kind of apoptotic stimuli. Moreover, increased NE permeability is not enough for a nuclear matrix protein to be redistributed to the cytosol: it also needs to be released from its interaction with the nuclear components which hold it in the nucleus. Such interactions, and how apoptotic stimuli affect them, most likely depend on the cellular context and the signaling pathways induced by the apoptotic stimuli. Furthermore, although the present study focused on the redistribution of several specific nuclear proteins such as nucleolin, other proteins which might even have an anti-apoptotic effect can also be redistributed. Thus, the outcome of stress-induced NPR needs to be further studied with respect to cell type and apoptotic stimulus of interest. Nonetheless, it seems that NPR itself, at least as studied in our system here, does not induce cell death per se, since FLAG-Bax KASH was not toxic.
Our discovery of a non-canonical action of Bax on the nuclear membrane may have implications for the development of drugs based on the Bcl-2 family. So far, these drugs are BH3 mimetics, that is, they block the action of Bcl-2-like survival factors. Since Bcl-x L is unable to inhibit Bax-induced NPR, these compounds may not regulate this particular process. Thus, for future drug development, one needs to consider that activation or inhibition of Bax action can also affect the nucleus and that standard approaches based on the interaction between Bax and anti-apoptotic members of the Bcl-2 family may not be sufficient to obtain a therapeutically effective drug.
